Search Results 751-760 of 23466 for B cell lymphomas
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Testing the Addition of an Anti-cancer ...
Cutaneous B-cell lymphoma; Cutaneous T-cell lymphoma; Dermatofibrosarcoma protuberans; Extramammary Paget's disease; Merkel cell carcinoma; Sebaceous ...
Rochester, MN. Area of Focus: Light therapy, Cutaneous t-cell lymphoma, Cutaneous b-cell lymphoma, Atopic dermatitis, Dermatitis, ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma.
It is also used together with other medicines to treat diffuse large B-cell lymphoma (DLBCL) in people who have not received previous treatment. Rituximab ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...
Bone marrow transplant, CAR-T cell therapy, Allogeneic stem cell transplant, Autologous stem cell transplant, Acute lym...phocytic leukemia, B-cell lymphoma ...
... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. In the Loop ...
... Cellular therapy, B-cell lymphoma, ...Lymphoma, Diffuse large b-cell lymphoma, Hairy cell leukemia, Non-Hodgkin lymphoma, T-cell lymphoma, Cutaneous t-cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.